Brevan Howard Capital Management LP Edgewise Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 25,346 shares of EWTX stock, worth $648,097. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,346
Previous 11,251
125.28%
Holding current value
$648,097
Previous $300,000
125.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EWTX
# of Institutions
215Shares Held
98.3MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$384 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$228 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$157 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$154 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$128 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.62B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...